Age
Item
age at least 18 years.
boolean
C0001779 (UMLS CUI [1])
Insulin regime Non-Insulin-Dependent Diabetes Mellitus
Item
type 2 diabetes treated with insulin therapy for at least 6 months prior to study enrolment.
boolean
C0557978 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
hba1c between 58 and 108 mmol/mol (7.5 and 12.0%) inclusive.
boolean
C0474680 (UMLS CUI [1])
Age
Item
age at least 18 years.
boolean
C0001779 (UMLS CUI [1])
Insulin regime Non-Insulin-Dependent Diabetes Mellitus
Item
type 2 diabetes treated with insulin therapy for at least 6 months prior to study enrolment.
boolean
C0557978 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
hba1c between 58 and 108 mmol/mol (7.5 and 12.0%) inclusive.
boolean
C0474680 (UMLS CUI [1])
Animal Insulin prescribed
Item
participant is currently prescribed animal insulin.
boolean
C0003062 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0278329 (UMLS CUI [1,3])
Insulin Daily Dose
Item
total daily dose of insulin (tdd) is >1.75 iu/kg at entry to the study.
boolean
C0021641 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
Comorbidity compromises Patient safety | Cystic Fibrosis | Mental Disorders, Severe | Eating Disorder | Eating Disorder Suspected | Medical condition Long-term Uncontrolled
Item
concomitant disease or condition that may compromise patient safety including and not limited to; cystic fibrosis, severe mental illness, a diagnosed or suspected eating disorder or any uncontrolled long term medical condition.
boolean
C0009488 (UMLS CUI [1,1])
C2945640 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])
C0010674 (UMLS CUI [2])
C4046029 (UMLS CUI [3])
C0013473 (UMLS CUI [4])
C0013473 (UMLS CUI [5,1])
C0750491 (UMLS CUI [5,2])
C3843040 (UMLS CUI [6,1])
C0443252 (UMLS CUI [6,2])
C0205318 (UMLS CUI [6,3])
Artificial cardiac pacemaker | Neurostimulator
Item
has a pacemaker or any other neurostimulators.
boolean
C0030163 (UMLS CUI [1])
C0582124 (UMLS CUI [2])
Oral steroid therapy Medical condition | Oral steroid therapy Chronic condition | Intramuscular steroid therapy Medical condition | Intramuscular steroid therapy Chronic condition | Steroid therapy Intravenous Medical condition | Steroid therapy Intravenous Chronic condition
Item
currently prescribed oral, intramuscular or intravenous steroid therapy for any acute or chronic condition or requires it during the study period.
boolean
C0574135 (UMLS CUI [1,1])
C3843040 (UMLS CUI [1,2])
C0574135 (UMLS CUI [2,1])
C4315615 (UMLS CUI [2,2])
C0585373 (UMLS CUI [3,1])
C3843040 (UMLS CUI [3,2])
C0585373 (UMLS CUI [4,1])
C4315615 (UMLS CUI [4,2])
C0149783 (UMLS CUI [5,1])
C1522726 (UMLS CUI [5,2])
C3843040 (UMLS CUI [5,3])
C0149783 (UMLS CUI [6,1])
C1522726 (UMLS CUI [6,2])
C4315615 (UMLS CUI [6,3])
Dialysis | Dialysis Planned
Item
currently receiving dialysis treatment or planning to receive dialysis during the study.
boolean
C0011946 (UMLS CUI [1])
C0011946 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
Pregnancy | Pregnancy, Planned
Item
women who are pregnant, plan to become pregnant or become pregnant during the study.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Study Subject Participation Status | Glucose monitoring device Affecting Glucose measurement | Investigational New Drugs Affecting Glucose measurement | Glucose monitoring device Affecting Blood glucose management | Investigational New Drugs Affecting Blood glucose management
Item
participating in another study of a glucose monitoring device or drug that could affect glucose measurements or management.
boolean
C2348568 (UMLS CUI [1])
C0202048 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0337438 (UMLS CUI [2,3])
C0013230 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0337438 (UMLS CUI [3,3])
C0202048 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C1638311 (UMLS CUI [4,3])
C0013230 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C1638311 (UMLS CUI [5,3])
Glucose monitoring system Sensor Based | Glucose monitoring system Retrospective
Item
currently using / has previously used a sensor based glucose monitoring system (including retrospective glucose monitoring system) within the last 6 months.
boolean
C3873850 (UMLS CUI [1,1])
C0872382 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])
C3873850 (UMLS CUI [2,1])
C1514923 (UMLS CUI [2,2])
Continuous subcutaneous infusion of insulin
Item
currently using continuous subcutaneous insulin infusion (csii).
boolean
C0393124 (UMLS CUI [1])
Hypersensitivity MEDICAL ADHESIVE | Hypersensitivity Suspected MEDICAL ADHESIVE
Item
known (or suspected) allergy to medical grade adhesives.
boolean
C0020517 (UMLS CUI [1,1])
C0726995 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0726995 (UMLS CUI [2,3])
Study Subject Participation Status Inappropriate
Item
in the investigator's opinion the participant is unsuitable to participate due to any other cause/reason.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])